MX2009012085A - Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos. - Google Patents
Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos.Info
- Publication number
- MX2009012085A MX2009012085A MX2009012085A MX2009012085A MX2009012085A MX 2009012085 A MX2009012085 A MX 2009012085A MX 2009012085 A MX2009012085 A MX 2009012085A MX 2009012085 A MX2009012085 A MX 2009012085A MX 2009012085 A MX2009012085 A MX 2009012085A
- Authority
- MX
- Mexico
- Prior art keywords
- epitopes
- methods
- antibodies
- antibody ligands
- directed expansion
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000003446 ligand Substances 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención comprende un procedimiento para seleccionar y elaborar anticuerpos útiles para propósitos terapéuticos, profilácticos, de diagnóstico o de investigación utilizando mezclas de epítopo péptido sintetizadas a través de síntesis de fase sólida, dicho procedimiento se define por un grupo de reglas con respecto a la identidad y la frecuencia de ocurrencia de aminoácidos que substituyen una base o aminoácido nativo de un epítopo conocido. Los anticuerpos resultantes están relacionados con, pero son distintos de, anticuerpos que se unen al epítopo conocido.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92822507P | 2007-05-07 | 2007-05-07 | |
| US99928307P | 2007-10-16 | 2007-10-16 | |
| US99928407P | 2007-10-16 | 2007-10-16 | |
| US12468908P | 2008-04-17 | 2008-04-17 | |
| PCT/US2008/005919 WO2009023047A2 (en) | 2007-05-07 | 2008-05-07 | Methods for the directed expansion of epitopes for use as antibody ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009012085A true MX2009012085A (es) | 2010-01-20 |
Family
ID=40351332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009012085A MX2009012085A (es) | 2007-05-07 | 2008-05-07 | Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100298547A1 (es) |
| EP (1) | EP2157980A2 (es) |
| JP (1) | JP2010540410A (es) |
| KR (1) | KR20100019487A (es) |
| CN (1) | CN101848731A (es) |
| AU (1) | AU2008287530A1 (es) |
| BR (1) | BRPI0811293A2 (es) |
| CA (1) | CA2686817A1 (es) |
| IL (1) | IL201997A0 (es) |
| MX (1) | MX2009012085A (es) |
| WO (1) | WO2009023047A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP3467A (en) | 2007-10-16 | 2015-11-30 | Peptimmune Inc | Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
| US8546532B2 (en) * | 2008-04-17 | 2013-10-01 | Declion Pharmaceuticals, Inc. | Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
| US8389689B2 (en) * | 2009-10-28 | 2013-03-05 | Janssen Biotech, Inc. | Anti-GLP-1R antibodies and their uses |
| KR101694523B1 (ko) | 2015-07-01 | 2017-01-23 | 박성진 | 위험을 알리는 cctv 카메라용 브라켓 |
| CN111363043B (zh) * | 2020-04-09 | 2021-07-23 | 福州迈新生物技术开发有限公司 | 抗cd20蛋白单克隆抗体、细胞系及其制备方法和应用 |
| CN112661816B (zh) * | 2021-01-13 | 2022-10-11 | 江西省人民医院 | 用于利妥昔单抗血药浓度检测的人工抗原及试剂盒 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
| PT735893E (pt) * | 1993-09-14 | 2009-03-06 | Pharmexa Inc | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária |
| US6093396A (en) * | 1996-09-27 | 2000-07-25 | Diamyd Therapeutics Ab | Modified glutamic acid decarboxylase (GAD) |
| FR2765688B1 (fr) * | 1997-07-04 | 1999-09-10 | Pasteur Institut | Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications |
| US6541011B2 (en) * | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
| US7118874B2 (en) * | 1998-10-09 | 2006-10-10 | Variation Biotechnologies Inc. | Immunogenic formulation and process for preparation thereof |
| WO2002059143A2 (en) * | 2001-01-24 | 2002-08-01 | President And Fellows Of Harvard College | Therapeutic peptides for demyelinating conditions |
| JP2004085206A (ja) * | 2002-08-22 | 2004-03-18 | Ajinomoto Co Inc | タンパク質間の相互作用界面情報を用いた疾患関連アミノ酸残基の特定方法およびそれを用いた薬物スクリーニング法 |
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
| DE102004041964B4 (de) * | 2004-08-04 | 2012-04-26 | Schaeffler Technologies Gmbh & Co. Kg | Maschinenelement für Wälzbelastung |
| EP1676859A1 (en) * | 2004-12-30 | 2006-07-05 | Pevion Biotech Ltd. | Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| US20090104216A1 (en) * | 2005-06-01 | 2009-04-23 | Variation Biotechnologies, Inc. | Peptide-Based Influenza Vaccine Formulation |
| US20090162383A1 (en) * | 2006-12-26 | 2009-06-25 | Padlan Eduardo A | Method for designing vaccines against constantly mutating pathogens |
-
2008
- 2008-05-07 JP JP2010507464A patent/JP2010540410A/ja active Pending
- 2008-05-07 WO PCT/US2008/005919 patent/WO2009023047A2/en not_active Ceased
- 2008-05-07 CA CA002686817A patent/CA2686817A1/en not_active Abandoned
- 2008-05-07 MX MX2009012085A patent/MX2009012085A/es not_active Application Discontinuation
- 2008-05-07 BR BRPI0811293A patent/BRPI0811293A2/pt not_active IP Right Cessation
- 2008-05-07 EP EP08827320A patent/EP2157980A2/en not_active Withdrawn
- 2008-05-07 US US12/451,323 patent/US20100298547A1/en not_active Abandoned
- 2008-05-07 KR KR1020097025559A patent/KR20100019487A/ko not_active Withdrawn
- 2008-05-07 CN CN200880023441A patent/CN101848731A/zh active Pending
- 2008-05-07 AU AU2008287530A patent/AU2008287530A1/en not_active Abandoned
-
2009
- 2009-11-08 IL IL201997A patent/IL201997A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL201997A0 (en) | 2010-06-16 |
| EP2157980A2 (en) | 2010-03-03 |
| AU2008287530A1 (en) | 2009-02-19 |
| WO2009023047A3 (en) | 2009-05-28 |
| US20100298547A1 (en) | 2010-11-25 |
| BRPI0811293A2 (pt) | 2017-05-16 |
| CA2686817A1 (en) | 2009-02-19 |
| KR20100019487A (ko) | 2010-02-18 |
| JP2010540410A (ja) | 2010-12-24 |
| CN101848731A (zh) | 2010-09-29 |
| WO2009023047A2 (en) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007120834A3 (en) | Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability | |
| NZ589302A (en) | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders | |
| MX2009012085A (es) | Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos. | |
| MX2009006199A (es) | Formulacion parenteral de anticuerpos abeta. | |
| WO2011073954A3 (en) | Novel antagonist antibodies and their fab fragments against gpvi and uses thereof | |
| MX359384B (es) | Conjunto mejorado de anticuerpos bisespecificos. | |
| EA201070539A1 (ru) | НОВЫЕ АНТИТЕЛА, СПЕЦИФИЧНЫЕ К β-АМИЛОИДНЫМ ПЕПТИДАМ, И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ДИАГНОСТИЧЕСКИХ ИЛИ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| NZ701769A (en) | Coiled coil and/or tether containing protein complexes and uses thereof | |
| MX2012011405A (es) | Anticuerpo biespecifico psmaxcd3 de simple cadena especifico de especies cruzadas. | |
| WO2011147982A3 (en) | Monoclonal antibodies against her2 epitope | |
| EA201000207A1 (ru) | Новые иммуногенные эпитопы для иммунотерапии | |
| EP3210625A3 (en) | Therapeutic peptides comprising antibodies binding to mhc class 1 polypeptide related sequence a (mica) | |
| EP3339322A3 (en) | Immunoglobulin single variable domain antibodies with a c-terminal extension for reduced immunogenicity | |
| WO2012125733A3 (en) | Antibody screening methods | |
| PH12014502669A1 (en) | Therapeutic agent or prophylactic agent for dementia | |
| WO2008098917A3 (en) | Novel antibodies against igf-ir | |
| MX2012002458A (es) | Anticuerpos anti-cdcp1 humanizados. | |
| MX2010001237A (es) | Nuevos anticuerpos. | |
| MX2010006044A (es) | Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion. | |
| JP2013121977A5 (es) | ||
| NZ578068A (en) | Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens | |
| JO2991B1 (ar) | بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17 | |
| WO2005030806A3 (en) | Norovirus monoclonal antibodies and peptides | |
| WO2006116442A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| RU2016137486A (ru) | Новое антитело против pai-1 человека |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |